Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event

Mohamed El-Kassas; Sherif Elbehiry; Enas Rezk; Dalia Omran; Ahmed Sherief; Mohamed Eltabbakh; Inas Moaz; Adel TEl ahan; Mohammad Abdalgaber; Haidy Khalil; Mohamed Alboraie; Amr El Fouly; Mohammed Aboul-Ezz; Amany Wahb; Ahmed Madkour

doi:https://doi.org/10.1016/j.clinre.2022.102042

Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event

Identifier:nobleid.org/w1/20260418/A843FD0D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A843FD0D.svg?ark=w1%2F20260418%2FA843FD0D)](https://nobleid.org/work/w1/20260418/A843FD0D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Discontinuing directly acting antivirals during hepatitis C treatment: highlighting an infrequent but hostile event

Identifier:nobleid.org/w1/20260418/A843FD0D

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/A843FD0D.svg?ark=w1%2F20260418%2FA843FD0D)](https://nobleid.org/work/w1/20260418/A843FD0D)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work